Rosenblatt Maintains Buy on Imax, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel has reiterated a Buy rating for Imax (NYSE:IMAX) and maintained a price target of $28.
October 31, 2024 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel has reiterated a Buy rating for Imax and maintained a price target of $28, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and a $28 price target by Rosenblatt suggests a positive outlook for Imax, likely boosting investor confidence and potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100